Trabodenoson (INO-8875) 是一种腺苷模拟物,是高选择性的腺苷 A1 受体 (Adenosine A1 receptor) 的激动剂。Trabodenoson (INO-8875) 可用于原发性开角型青光眼的研究。
生物活性 | Trabodenoson (INO-8875), an adenosine mimetic, is a highly selectiveAdenosine A1 receptoragonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma[1].
|
体外研究 (In Vitro) | Trabodenoson treatment significantly increaseS MMP-2 activity and MMP-14 abundance, while decreasing fibronectin and collagen IV expression[1].
|
体内研究 (In Vivo) | Trabodenoson (6.0%), demonstrating an average IOP drop of 2.45 ± 0.38 mm Hg in young mice over 7 days (downregulation)[1]. Topical trabodenoson significantly upregulates nestin expression in the ONH of induced eyes compared with vehicle-treated no-induced eyes[2]. Trabodenoson-treated eyes have significantly reduced optic nerve (ON) edema compared with vehicle-treated eyes. RGC counts are higher in Trabodenoson-treated eyes compared to vehicle (74% versus 47% of the contralateral eye)[2].
Animal Model: | Young (3-4 months old) and aged (12 months old)[1]. | Dosage: | 3% or 6% in 10 μL. | Administration: | Eye drop for 7 consecutive days. | Result: | Decreased IOP. |
Animal Model: | Rats[2]. | Dosage: | 3%. | Administration: | Topical delivery daily. | Result: | Had significantly reduced optic nerve (ON) edema. |
|
Clinical Trial | |
分子量 | |
性状 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Powder | -20°C | 3 years | | 4°C | 2 years | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
溶解性数据 | In Vitro: DMSO : 125 mg/mL(328.64 mM;Need ultrasonic) 配制储备液 1 mM | 2.6291 mL | 13.1454 mL | 26.2909 mL | 5 mM | 0.5258 mL | 2.6291 mL | 5.2582 mL | 10 mM | 0.2629 mL | 1.3145 mL | 2.6291 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: 10% DMSO 40%PEG300 5%Tween-80 45% saline Solubility: ≥ 2.08 mg/mL (5.47 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (5.47 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。 2. 请依序添加每种溶剂: 10% DMSO 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.08 mg/mL (5.47 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (5.47 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。 3. 请依序添加每种溶剂: 10% DMSO 90%corn oil Solubility: ≥ 2.08 mg/mL (5.47 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (5.47 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。 以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。 *以上所有助溶剂都可在本网站选购。
|